Cemtrex Inc. Series 1 Warrant
CETXW
CETXW was delisted on the 27th of January, 2022.
7 hedge funds and large institutions have $19K invested in Cemtrex Inc. Series 1 Warrant in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
171% more capital invested
Capital invested by funds: $7K → $19K (+$12K)
13% less funds holding
Funds holding: 8 → 7 (-1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$29 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
-$231 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9 |
CETXW Hedge Fund Activity: Q1 2019 in Review
7 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Cemtrex Inc. Series 1 Warrant (CETXW) for Q1 2019, worth a combined $19K — up 171% from $7K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CETXW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, adding an estimated $29. The largest seller was Bard Associates, cutting an estimated $231.
- 7 institutional investors held Cemtrex Inc. Series 1 Warrant (CETXW) as of Q1 2019, down from 8 in Q4 2018.
- Funds reported $19K of Cemtrex Inc. Series 1 Warrant stock for Q1 2019, up 171% quarter-over-quarter.
- 0 funds opened new Cemtrex Inc. Series 1 Warrant positions in Q1 2019 and 1 closed out, a net change of -1 holder.
- The largest Cemtrex Inc. Series 1 Warrant buyer in Q1 2019 was Susquehanna International Group, an estimated $29 added.
- The largest Cemtrex Inc. Series 1 Warrant seller in Q1 2019 was Bard Associates, an estimated $231 sold.
Based on aggregated 13F filings for Q1 2019.